Heres the simplified breakdown: GLP-1 helps suppress appetite GIP supports insulin function and metabolic balance Glucagon may help increase calorie burning and fat utilization That third mechanism may create a stronger overall metabolic effect compared to tirzepatide alone
Both activate the GLP-1 receptor, so taking them together is redundant overlapping agonism
Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide tablets [see Adverse Reactions (6)]
Its considered a quick-fix method that allows people to stop taking a substance immediately instead of gradually tapering off of it
High costs and challenging side effects havent stopped many people from clamoring to get the drugs, which can help patients lose 20% or more of their body weight
It was suggested that this was achieved by inhibiting the production of pro-inflammatory cytokines and reducing the increase in intestinal permeability (102)